KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Treasury Shares (2017 - 2025)

Twist Bioscience (TWST) has disclosed Treasury Shares for 9 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 14.79% to $3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Dec 2025, up 14.79% year-over-year, with the annual reading at $1.9 million for FY2025, 1.53% down from the prior year.
  • Treasury Shares for Q4 2025 was $3.0 million at Twist Bioscience, up from $1.9 million in the prior quarter.
  • The five-year high for Treasury Shares was $3.0 million in Q4 2025, with the low at $736.0 in Q1 2021.
  • Average Treasury Shares over 5 years is $1.5 million, with a median of $1.7 million recorded in 2023.
  • The sharpest move saw Treasury Shares tumbled 98.55% in 2021, then soared 173133.7% in 2022.
  • Over 5 years, Treasury Shares stood at $1605.0 in 2021, then soared by 113171.03% to $1.8 million in 2022, then skyrocketed by 33.06% to $2.4 million in 2023, then rose by 8.47% to $2.6 million in 2024, then grew by 14.79% to $3.0 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $3.0 million, $1.9 million, and $2.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.